A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2016
At a glance
- Drugs Surotomycin (Primary) ; Vancomycin
- Indications Clostridium infections; Diarrhoea
- Focus Therapeutic Use
- Sponsors Cubist Pharmaceuticals
- 17 Jul 2016 Results published in the Journal of Antimicrobial Chemotherapy (2016).
- 20 Sep 2011 Results were reported at the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 16 Jun 2011 Results have been reported in a Cubist Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History